Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Biotech
Travere chief makes way for former Amicus CEO—Chutes & Ladders
Travere chief makes way for former Amicus CEO. Ex-Cue CEO takes the reins at Lift. Nuclera’s new leader sets sights on growth.
Marissa Russo
,
Donavyn Coffey
,
Will Maddox
Sep 25, 2026 8:30am
Genentech inks $1.5B bispecific pact with fast-rising Earendil
Sep 25, 2026 2:51am
Roche pens $2B deal with Atavistik to discover new CVRM drugs
Sep 24, 2026 8:35am
Roche’s ph. 3 win tees up blockbuster fight with Novartis
Sep 23, 2026 3:50am
Roche’s GLP-1/GIP diabetes data fuel best-in-disease hopes
Sep 22, 2026 5:20am
Roche signs $1B Dualitas deal to collab on bispecific screening
Sep 17, 2026 8:07am